Kenneth Jacobs

Kenneth Jacobs

Company: Wugen

Job title: Vice President, Pharmacovigilance & Clinical Development


Driving Clinical Activity of TCR-T Cells in the Challenging Solid Tumour Setting 11:00 am

• Sharing developments in Wugen’s WU-CART-007 programme, an allogeneic, fractricide resistant CAR-T cell for the treatment of CD7 hematological malignancies • Sharing promising clinical data from dose escalation studies, with no GvHD and only minor CRS seen • Discussing future plansRead more

day: Day 1 – Track B – Morning

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.